Skip to content

Advertisement

  • Poster presentation
  • Open Access

Isolation, characterization and expression in Escherichia coli of a cDNA coding for a novel major wheat food allergen

  • Alexandra Schmidhuber1,
  • Sandra Pahr1,
  • Claudia Constantin2,
  • Nikos Papadopoulos3,
  • Chritof Ebner4,
  • Adriano Mari5,
  • Susanne Vrtala6 and
  • Rudolf Valenta7
Clinical and Translational Allergy20111(Suppl 1):P97

https://doi.org/10.1186/2045-7022-1-S1-P97

Published: 12 August 2011

Keywords

Food AllergySpecific ImmunotherapyPollen AllergyRecombinant AllergenAllergic Child

Introduction

Wheat (Triticum aestivum) is a main component of the daily diet but can cause three distinct forms of wheat allergy: Baker's asthma, wheat food allergy and wheat pollen allergy. The panel of wheat allergens is still incomplete. The aim of the study was to identify and characterize wheat allergens for the development of improved diagnostic tests and allergen-specific forms of treatment.

Methods

A cDNA library was screened with serum from wheat food allergic patients. The cDNAs coding for allergens were subjected to sequence comparison, cloned into E.coli expression vectors and recombinant allergens were purified. The IgE reactivity of the recombinant allergens was tested by non-denaturing RAST-based dot blot analysis with sera from clinically well defined patients suffering from wheat food allergy or Baker's Asthma.

Results

We isolated a cDNA coding for the C-terminal part of a low molecular weight glutenin which has not yet been described as an allergen. The C-terminal part as well as the full length protein were expressed as soluble proteins in E. coli and purified. More than 80% of wheat food allergic children (n=26) showed IgE reactivity with the complete recombinant glutenin whereas only 5% of Baker's Asthma patients (n=60) showed specific IgE reactivity.

Conclusion

We identified a low molecular weight as a novel major wheat food allergen which can be used for the development of component-resolved diagnostic tests for wheat food allergy and eventually for specific immunotherapy.

Authors’ Affiliations

(1)
Christian Doppler Laboratory for the development of allergen chips, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
(2)
Department of Patholphysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
(3)
Allergy and Immunology Research Centre, University of Athens, Athens, Greece
(4)
Ambulatory for Allergy and Clinical Immunology, Vienna, Austria
(5)
Centre for Clinical and Experimental Allergology, IDI-IRCCS, Rome, Italy
(6)
Christian Doppler Laboratory for the development of allergen chips, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
(7)
Christian Doppler Laboratory for Allergy Research, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria

Copyright

© Schmidhuber et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement